» Articles » PMID: 11470158

Molecular Cloning and Functional Expression Analysis of a CDNA for Human Hepassocin, a Liver-specific Protein with Hepatocyte Mitogenic Activity

Overview
Specialties Biochemistry
Biophysics
Date 2001 Jul 27
PMID 11470158
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

By means of differential cDNA expression cloning, we earlier isolated a novel rat cDNA and its protein, named hepassocin, which is upregulated during liver regeneration. Using the rat cDNA as a probe, we have now isolated human hepassocin cDNA encoding a protein of 312 amino acids, which has 81.4% and 83.8% identity, respectively, to rat hepassocin before and after elimination of its signal peptide. Dot blot analysis revealed that hepassocin mRNA was strongly expressed in adult liver, fairly strongly in fetal liver, and weakly in pancreas, but not in other tissues. Recombinant human hepassocin produced in Chinese hamster ovary (CHO) cells by the dihydrofolate reductase-methotrexate (DHFR--MTX) gene amplification method is a homodimer (68 kDa) and has mitogenic activities in hepatocytes of various animal species including rat, mouse, rabbit and dog, and the activity was lost with 2-mercaptoethanol treatment. These results suggest that hepassocin is a potent regulator in liver cell growth not only in rats but also in humans. Computer searches revealed that human hepassocin as well as rat hepassocin has a characteristic disulfide structure close to that of fibrinogen-gamma. We assume that this newly identified growth factor exerts functions in association with an extracellular matrix such as fibrinogen.

Citing Articles

Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation.

Miao X, Alidadipour A, Saed V, Sayyadi F, Jadidi Y, Davoudi M Acta Diabetol. 2024; 61(11):1339-1361.

PMID: 39031190 DOI: 10.1007/s00592-024-02335-9.


Fibrinogen-like 1: A hepatokine linking liver physiology to hematology.

Personnaz J, Guillou H, Kautz L Hemasphere. 2024; 8(7):e115.

PMID: 38966209 PMC: 11223652. DOI: 10.1002/hem3.115.


FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.

Huang Z, Wang Z, Xu C, Yan Y, Cao X, Zhang F Int J Med Sci. 2024; 21(8):1447-1460.

PMID: 38903931 PMC: 11186416. DOI: 10.7150/ijms.91874.


Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.

Huang S, Zhang J, He P, Cui X, Hou Y, Su W BMC Cancer. 2024; 24(1):557.

PMID: 38702629 PMC: 11067193. DOI: 10.1186/s12885-024-12313-7.


The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.

Sardo U, Perrier P, Cormier K, Sotin M, Personnaz J, Medjbeur T Blood. 2024; 143(13):1282-1292.

PMID: 38232308 PMC: 11103088. DOI: 10.1182/blood.2023022724.